AstraZeneca’s mRNA-Based AZD8601 Succeeds At Phase II, Propelling Moderna Into Heart Space

 
• By Ayisha Sharma
  
Moderna's mRNA Technology Seems Applicable Outside Of Infectious Diseases • Source: Alamy

More from Clinical Trials

More from R&D